Acceptance of non-plant-derived-artemisinin offers potential to increase access to malaria treatment (issued 8 May 2013) pdf
Assessment of response to position paper "WHO response to the USFDA warning letter issued to Mylan Laboratories Ltd, Nashik" pdf
Updated CD4 technologies under assessment pdf
Updated Cholera rapid diagnostic tests under assessment pdf
Concept note: Requirements for provision of a ‘bridging’ report for SRA-approved medicines for consideration of registration in non-SRA settings docx
Copenhagen hotels offering preferred rates 2017 pdf
Disclaimer for WHO list of prequalified diagnostic products pdf
Follow-up on the suspension of eight (8) models of vaccine refrigerators, from Vestfrost A/S, Esberg, Denmark pdf
Frequently asked questions by the manufacturing, trial and testing organizations in connection with some of their constraints faced during the COVID-19 outbreak pdf
Updated G6PD deficiency tests under assessment pdf
Updated HBsAG assays under assessment pdf
Updated Hepatitis C assays under assessment pdf
Updated HIV enzyme immuno assays under assessment pdf
HIV mid-year market memo, 2018 20 June 2018 (Clinton Health Access Initiative) PDF
Updated HIV nucleic tests under assessment pdf
Updated HIV rapid tests under assessment pdf
Updated HIV/syphilis rapid combo tests under assessment pdf
HIV/syphilis rapid tests under assessment pdf
IMDRF collated table pdf
Information on the GMP status of Micro Labs Kumbalgodu (ML08) manufacturing facility pdf
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 14–27 September 2018: Agenda pdf
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Agenda pdf
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Programme description pdf
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 24–27 September 2018: Programme description pdf
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 2–5 December 2019: Agenda pdf
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers, Denmark, 18‒21 September 2017: Background for WHO vector control prequalification pdf
List of WHO prequalification evaluating laboratories pdf
List of WHO-contracted laboratories (29 June 2021) docx
Updated Malaria tests under assessment pdf
Male circumcision devices under assessment pdf
NMRAs participating in the WHO collaborative procedure pdf
Notice of Concern (NOC) for Panexcell Clinical Lab Pvt Ltd pdf
One-third of antimalarial medicines tested in six African countries fail to meet international quality standards (issued 25 February 2011) pdf
Other HIV assays under assessment pdf
Potential risk of freezing in some Vestfrost fridges pdf
Principles for prioritizing dossiers within the WHO Prequalification Team: medicines (27 October 2011) pdf
Product Recall - Moxifloxacin 100mg Dispersible Tablets (TB342): Batch BMC5801A pdf
Requirements for provision of a ‘bridging’ report for SRA-approved medicines for consideration of registration in non-SRA settings, Annex 8 docx
Summary of FPPs and APIs invited for prequalification xlsx
Updated Syphilis rapid tests under assessment pdf
The Expert Review Panel: information note (8 February 2019) pdf
Update on COVID-19 in vitro diagnostics listed by national regulatory authorities in IMDRF jurisdictions (8 April 2020) pdf
WHO EUAL Delisting: Product: ReEBOVTM Antigen Rapid Test Kit EUAL number: EA 0011-011-00 pdf
WHO EUL Public Report for SARS-CoV-2: Product: Sure Status COVID-19 Antigen Card Test EUL Number: EUL-0590-010-00 pdf
WHO EUL Public Report for SARS-CoV-2: Product: Veri-Q PCR 316 Coronovirus disease 2019 (COVID-19) EUL Number: EUL-0495-188-00 pdf
WHO EUL Public Report for SARS-CoV-2: Product: Veri-Q PCR 316 Coronovirus Disease 2019 EUL Number: EUL-0495-188-00 pdf
WHO List of Prequalified Quality Control Laboratories pdf
Withdrawal Notice - AmBisome Liposomal Amphotericin B 50mg Powder for Concentrate for Dispersion for Infusion (HA705) - Minisart® Filter pdf
